VENDORFY24MODEX THERAPEUTICS, INCTotal obligated$51MContracts2Agencies1NAICS used1HQ stateMAStandout signalsBIGGEST DEAL$51.0MADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR T — Department of Health and Human ServicesReceipts2024-09-27$51MADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.MODEX THERAPEUTICS, INCDepartment of Health and Human Services